Insight Molecular Diagnostics Cash on Hand 2014-2025 | IMDX
Insight Molecular Diagnostics cash on hand from 2014 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Insight Molecular Diagnostics Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $9 |
| 2023 | $9 |
| 2022 | $20 |
| 2021 | $34 |
| 2020 | $8 |
| 2019 | $22 |
| 2018 | $8 |
| 2017 | $8 |
| 2016 | $12 |
| 2015 | $11 |
| 2014 | $4 |
| 2013 | $5 |
|
Insight Molecular Diagnostics Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-09-30 | $19 |
| 2025-06-30 | $24 |
| 2025-03-31 | $31 |
| 2024-12-31 | $9 |
| 2024-09-30 | $3 |
| 2024-06-30 | $9 |
| 2024-03-31 | $6 |
| 2023-12-31 | $9 |
| 2023-09-30 | $14 |
| 2023-06-30 | $18 |
| 2023-03-31 | $12 |
| 2022-12-31 | $20 |
| 2022-09-30 | $32 |
| 2022-06-30 | $45 |
| 2022-03-31 | $21 |
| 2021-12-31 | $34 |
| 2021-09-30 | $44 |
| 2021-06-30 | $48 |
| 2021-03-31 | $60 |
| 2020-12-31 | $8 |
| 2020-09-30 | $11 |
| 2020-06-30 | $17 |
| 2020-03-31 | $17 |
| 2019-12-31 | $22 |
| 2019-09-30 | $20 |
| 2019-06-30 | $36 |
| 2019-03-31 | $40 |
| 2018-12-31 | $8 |
| 2018-09-30 | $12 |
| 2018-06-30 | $11 |
| 2018-03-31 | $14 |
| 2017-12-31 | $8 |
| 2017-09-30 | $12 |
| 2017-06-30 | $10 |
| 2017-03-31 | $13 |
| 2016-12-31 | $12 |
| 2016-09-30 | $15 |
| 2016-06-30 | $6 |
| 2016-03-31 | $8 |
| 2015-12-31 | $11 |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | $4 |
| 2013-12-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.190B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.527B | 42.25 |
| Tempus AI (TEM) | United States | $12.512B | 0.00 |
| Doximity (DOCS) | United States | $7.768B | 31.98 |
| Hims & Hers Health (HIMS) | United States | $7.144B | 58.11 |
| IRHYTHM HLDGS (IRTC) | United States | $5.386B | 0.00 |
| Hinge Health (HNGE) | United States | $3.411B | 0.00 |
| Heartflow (HTFL) | United States | $3.165B | 0.00 |
| Privia Health (PRVA) | United States | $2.868B | 179.38 |
| Inspire Medical Systems (INSP) | United States | $2.680B | 44.34 |
| 10x Genomics (TXG) | United States | $2.597B | 0.00 |
| Omnicell (OMCL) | United States | $2.267B | 46.35 |
| Azenta (AZTA) | United States | $1.840B | 75.47 |
| Enovis (ENOV) | United States | $1.371B | 7.20 |
| Clover Health Investments (CLOV) | United States | $1.312B | 0.00 |
| Schrodinger (SDGR) | United States | $1.237B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.051B | 0.00 |
| Phreesia (PHR) | United States | $0.988B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.868B | 0.00 |
| Talkspace (TALK) | United States | $0.656B | 132.00 |
| Standard BioTools (LAB) | United States | $0.600B | 0.00 |
| Claritev (CTEV) | United States | $0.503B | 0.00 |
| Evolent Health (EVH) | United States | $0.421B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.368B | 0.00 |
| Carlsmed (CARL) | United States | $0.334B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.334B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.317B | 0.00 |
| TruBridge (TBRG) | United States | $0.311B | 14.28 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.255B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.182B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.171B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.096B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.072B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| 111 (YI) | China | $0.049B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.023B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| PROFUSA (PFSA) | United States | $0.009B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |